万邦医药 (301520.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(万邦医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报
主要指标:
 营业收入(元) 293,304,171.94187,214,555.8690,172,342.02341,806,532.85240,653,628.05164,992,422.6272,058,423.64260,780,991.31-107,638,914.09
 营业利润(元) 81,466,520.5457,095,567.2132,127,485.39119,006,174.3485,574,889.7160,480,601.0228,504,379.46106,083,800.92-38,495,922.14
 利润总额(元) 84,055,703.2259,557,656.9532,375,766.77119,644,908.2885,943,354.5860,701,232.5128,440,663.92111,146,656.38-40,685,001.40
 净利润(元) 77,797,479.7355,032,956.0929,687,084.26108,091,849.3177,311,464.5353,820,558.4824,987,178.2198,733,804.38-35,825,370.60
 归属于母公司股东的净利润(元) 77,797,479.7355,032,956.0929,687,084.26108,091,849.3177,311,464.5353,820,558.4824,987,178.2198,733,804.38-35,825,370.60
盈利能力:
 销售毛利率(%) 43.1546.1146.9648.9451.3351.7052.7950.3850.8549.40
 销售净利率(%) 26.5229.4032.9231.6232.1332.6234.6837.8638.2233.28
 净资产收益率(%) 5.295.883.1012.04-16.46----
 总资产报酬率ROA(%) 5.225.643.1211.80-15.18----
 投入资本回报率ROIC(%) 5.233.732.0112.048.7615.017.2634.97-14.28
营运能力:
 存货周转率(次) 132.74105.86163.74314.33-123.12----
 应收账款周转率(次) 5.403.782.987.91-5.43----
 总资产周转率(次) 0.190.180.090.35-0.41----
偿债能力:
 资产负债率(%) 5.715.444.795.225.6017.13-18.04-19.15
 股东权益比率(%) 94.2994.5695.2194.7894.4082.87100.0081.96-80.85
 已获利息倍数(倍) -30.36-26.80-23.29-24.93-252.09-340.96-679.25-123.98--120.91
 流动比率 19.4020.3423.8120.3518.514.31-4.39-4.63
 速动比率 19.1820.1023.5520.1318.304.13-4.31-4.52
发展能力:
 营业收入增长率(%) 21.8813.4725.1431.0733.4353.28-23.54-7.38
 营业利润增长率(%) -4.80-5.6012.7112.1812.2857.11-21.68--11.46
 税后利润增长率(%) 0.632.2518.819.4812.1750.23104.9520.6016.29-9.50
 净资产增长率(%) 5.25285.46318.87341.48-43.44-42.40-40.98
 总资产增长率(%) 5.38237.81270.86281.76-39.94-42.65-47.26

前瞻产业研究院